New pill shows promise for social anxiety in early trial

NCT ID NCT06693609

Completed Symptom relief Sponsor: atai Therapeutics, Inc. Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jul 31, 2026 · Updated 1 time

Summary

This study tested a new oral drug called EMP-01 in 70 adults with social anxiety disorder. Participants received either EMP-01 or a placebo for a short time to see if the drug is safe and helps reduce anxiety in social situations. The main goal was to check for side effects, while also looking at whether symptoms improved over six weeks.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SOCIAL ANXIETY DISORDER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

social phobia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

SOCIAL ANXIETY DISORDER

Contacts and locations

Locations

MAC Clinical Research - Greater Manchester

Manchester, Greater Manchester, M13 9NQ, United Kingdom
MAC Clinical Research - Lancashire

Blackpool, Lancashire, FY2 0JH, United Kingdom
MAC Clinical Research - Merseyside

Liverpool, Merseyside, L34 1BH, United Kingdom
MAC Clinical Research - South Staffordshire

Bridgetown, Cannock, Staffordshire, S75 3DL, United Kingdom
MAC Clinical Research - South Yorkshire

Tankersley, South Yorkshire, S75 3DL, United Kingdom
MAC Clinical Research - Teesside

Thornaby, Stockton-on-Tees, TS17 6EW, United Kingdom
MAC Clinical Research Centre, West Yorkshire

Leeds, LS10 1DU, United Kingdom

More trials for these conditions

Other studies related to the condition(s) this trial covers.